LANSING, Mich., April 28, 2014 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the leading developer of advanced spider silk based fibers, today invites shareholders, and other followers of the Company's developments, to visit the new Kraig investor relations website at www.kblbinvestors.com. The Company is also announcing the launch of social media pages at Facebook and Twitter. The Company may add additional pages at other sites.
"Kraig has been a true trailblazer in applied biotechnology. As we've concentrated on making discoveries in the laboratory, we've held off from establishing a social media presence and avoided prematurely incorporating many other public relations tools. As the Company moves towards commercialization, we've achieved a stage in our growth where we can benefit from improved communications. We need to inform industry about what we've accomplished, both in the laboratory and in executing our recombinant spider silk commercialization plan," said Company Founder and CEO, Kim K. Thompson.
"Kraig's shareholders are one of the keys to our success and these tools should help us keep them informed. Some of the website content will be designed specifically with our shareholders in mind.
"We view ourselves as the world leader in our exciting field of biotechnology innovation. As such, we are sensitive to the competitive environment surrounding our inventions and laboratory discoveries. We will remain guarded on certain details that could give aid to potential competitors, but, as we advance our business model, we plan on revealing additional information in upcoming Company press releases," Thompson concluded.
The Company intends to distribute information on these sites in compliance with Securities and Exchange Commission's Regulation Fair Disclosure. For further Regulation FD information, please go to: http://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171513574#.UxdPrc7WBxA.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc